학술논문

Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
Document Type
Journal
Source
BRITISH JOURNAL OF HAEMATOLOGY; AUG 15 2021, 5p.
Subject
Language
English
ISSN
13652141